Biologists at UC San Diego have discovered a chemical that offers a completely new and promising direction for the development of drugs to treat metabolic disorders such as type 2 diabetes—a major public health concern in the United States due to the current obesity epidemic.
Researchers at the UC San Diego School of Medicine are evaluating a new social media tool called Wellaho to treat patients with type I and II diabetes.
Middle-aged women who report having been physically abused as children are about two times more likely than other women their age to have high blood pressure, high blood sugar, a larger waistline and poor cholesterol levels, according to a new study published by the American Psychological Association.
Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks, new Johns Hopkins research suggests.
Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.
Gestational diabetes occurs when a woman exhibits high blood sugar for the first time during pregnancy. Scientists have determined a correlation between maternal weight and risk of gestational diabetes. In an effort to reach more women at risk of having heavy babies, the American Diabetes Association (ADA) recently broadened the diagnostic criteria for gestational diabetes.
Intensive early treatment of type 2 diabetes slows down progression of the disease by preserving the body’s insulin-producing capacity, a UT Southwestern study has shown.
Women with polycystic ovary syndrome (PCOS) who also have obstructive sleep apnea have at least three times the risk of having prediabetes compared with women who do not have PCOS, according to a new study. The results will be presented Tuesday at The Endocrine Society’s 94th Annual Meeting in Houston.
A large study in people at risk of diabetes has found a direct association between the presence of a small genetic alteration in a hormone receptor and increased body fat and insulin resistance. The results, to be presented Tuesday at The Endocrine Society’s 94th Annual Meeting in Houston, suggest an adverse role for a previously described genetic variant, the BclI polymorphism.
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society’s 94th Annual Meeting in Houston.
Two new blood tests for vitamin D are inaccurate in at least 40 percent of laboratory specimens analyzed, a new study finds. The results will be presented Monday at The Endocrine Society’s 94th Annual Meeting in Houston.
A computer-software program more effectively controlled blood-sugar levels among critically ill patients than nurse-directed care did, according to the first large clinical trial of its kind. The results will be presented at The Endocrine Society’s 94th Annual Meeting in Houston.
A new variety of long-lasting insulin, called insulin degludec, lowers the risk of nighttime low blood sugar in elderly diabetic adults compared with insulin glargine, a systematic review of diabetes studies has found. The meta-analysis of phase 3 clinical trials will be presented Monday at The Endocrine Society’s 94th Annual Meeting in Houston.
A new study presents more evidence of a possible link between low vitamin D levels and a higher risk of Type 2 diabetes and heart disease. The results will be presented Saturday at The Endocrine Society’s 94th Annual Meeting in Houston.
Adults who are exposed to secondhand smoke have higher rates of obesity and Type 2 diabetes than do nonsmokers without environmental exposure to tobacco smoke, a new study shows. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston, also found that these diabetic patients lost weight and lowered their blood pressure.
An experimental insulin drug prevented low blood sugar among diabetic patients more often than a popular drug on the market, a new study finds. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented Saturday at The Endocrine Society’s 94th Annual Meeting in Houston.
Type 2 diabetes often reverses after modified weight loss surgery, especially when the duration of diabetes is less than 10 years, a new study finds. The results will be presented Tuesday at The Endocrine Society’s 94th Annual Meeting in Houston.
The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia, a form of low blood sugar that occurs after a meal, a preliminary study finds. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality, a new study determines. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
A fungicide used on farm crops can induce insulin resistance, a new tissue-culture study finds, providing another piece of evidence linking environmental pollutants to diabetes. The results will be presented Saturday at The Endocrine Society’s 94th Annual Meeting in Houston.
Many patients with type 2 diabetes may be aspirin resistant. That means the standard aspirin dose may not protect them against blood clots that cause heart attacks and strokes among diabetics, a new clinical study finds. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death, a large new analysis finds. The results will be presented Sunday at The Endocrine Society’s 94th Annual Meeting in Houston.
A new study shows that although gastric bypass surgery reverses Type 2 diabetes in a large percentage of obese patients, the disease recurs in about 21 percent of them within three to five years. The study results will be presented Saturday at The Endocrine Society’s 94th Annual Meeting in Houston.
Preventing diabetes or delaying its onset has been thought to stave off cognitive decline -- a connection strongly supported by the results of a 9-year study led by researchers at the University of California, San Francisco (UCSF) and the San Francisco VA Medical Center.
African-American women lost about 10 percent less of their excess weight after gastric bypass than their Caucasian counterparts, but if Type 2 diabetes was present, weight loss and the rate of diabetes remission was about the same, according to a new study*
Some bariatric surgery patients are more likely to achieve complete remission of their Type 2 diabetes than others, according to a new study*
In many obese diabetic patients, one of the most dreaded complications of Type 2 diabetes can be put into remission or prevented entirely with bariatric surgery, according to a new study* from the Cleveland Clinic
A future weapon in the battle against obesity and diabetes could come in the form of an oil derived from the seeds of wild almond trees, according to researchers at Missouri University of Science and Technology.
A simple, inexpensive method for preventing type 2 diabetes that relies on calling people and educating them on the sort of lifestyle changes they could make to avoid developing the disease has proven effective in a study conducted by researchers at the University of California, San Francisco (UCSF) and the City of Berkeley Department of Public Health.
Obstructive sleep apnea (OSA) is independently associated with diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM), according to a new study from researchers in the UK.
Research published in the Genetics Society of America’s June 2012 issue of the journal GENETICS suggests a gene related to Alzheimer’s disease is also involved in the insulin pathway, which may explain the link between Alzheimer’s and diabetes.
Scientists have been puzzled by the fact that after people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. Dr. Myra Lipes and team at Joslin Diabetes Center have identified the misstep that sparks this runaway chronic damage and a promising way to block it.
A study by a team of clinicians and researchers at Joslin Diabetes Center in Boston has shown for the first time that patients with diabetes who enrolled in a short-term intensive weight management program were able to lose weight and keep it off on their own for four years. The findings suggest an alternative course to bariatric surgery in the fight against type 2 diabetes.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Researchers at McMaster University have discovered that long-term insulin use does not harm people with diabetes or pre-diabetes or put them at risk of heart attacks, strokes or cancer.
Millions of pre-diabetic Americans may be at increased risk of future stroke, say researchers at the University of California, San Diego School of Medicine in a new meta-analysis of epidemiological studies, but the precise degree of that threat is confounded by differing medical definitions and factors that remain unknown or unmeasured.
Drugs for type 2 diabetes can contribute to unwanted side effects, but Washington University researchers have found that in mice, an investigational drug appears to improve insulin sensitivity without side effects. The medicine works through a different pathway, which could provide additional targets for treating insulin resistance and diabetes.
Researchers at Joslin Diabetes Center have shown that while a type of “good” fat found in the body can be activated by cold temperatures, it is not able to be activated by the drug ephedrine.
An innovative model of diabetes care developed in southeastern Minnesota will be demonstrated at a national health forum this week in Washington, D.C.
Aiming for & incentivizing strict BP control for all patients means some are being over-treated -- but an individualized approach could help.
The number of Americans suffering from kidney stones between 2007 and 2010 nearly doubled since 1994, according to a study by researchers at the University of California, Los Angeles (UCLA) and RAND.
The severity of sleep disordered breathing and nocturnal hypoxemia independently predict both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.
University of Michigan Health System study shows Bcl10 protein helps the free fatty acids found in high fat foods impair insulin action and raise blood sugar.
For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.
Extended daily fasting overrides harmful effects of a high-fat diet.
A new UCLA study is the first to show how a diet steadily high in fructose slows the brain, hampering memory and learning--and how omega-3 fatty acids can minimize the damage.
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.
The University of Virginia School of Medicine has launched the first U.S. outpatient trial of a UVA-developed artificial pancreas that could make it easier for type 1 diabetes patients to manage their condition.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right